Literature DB >> 17503138

Neuropsychological symptoms in paraneoplastic disorders.

Raymond Voltz1.   

Abstract

Neuropsychological symptoms may rarely be part of a paraneoplastic neurological syndrome, mainly as limbic encephalitis. As the tumour will not be known in most patients upon presentation to the neurologists, state-of-the art diagnosis including the use of anti-neuronal antibodies and FDG-PET is essential for adequate management of these patients.

Entities:  

Mesh:

Year:  2007        PMID: 17503138     DOI: 10.1007/s00415-007-2020-7

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  24 in total

Review 1.  Paraneoplastic syndromes involving the nervous system.

Authors:  Robert B Darnell; Jerome B Posner
Journal:  N Engl J Med       Date:  2003-10-16       Impact factor: 91.245

2.  Neurosyphilis and paraneoplastic limbic encephalitis: important differential diagnoses.

Authors:  R Scheid; R Voltz; T Vetter; O Sabri; D Y von Cramon
Journal:  J Neurol       Date:  2005-04-01       Impact factor: 4.849

3.  Management of paraneoplastic neurological syndromes: report of an EFNS Task Force.

Authors:  C A Vedeler; J C Antoine; B Giometto; F Graus; W Grisold; I K Hart; J Honnorat; P A E Sillevis Smitt; J J G M Verschuuren; R Voltz
Journal:  Eur J Neurol       Date:  2006-07       Impact factor: 6.089

4.  A serologic marker of paraneoplastic limbic and brain-stem encephalitis in patients with testicular cancer.

Authors:  R Voltz; S H Gultekin; M R Rosenfeld; E Gerstner; J Eichen; J B Posner; J Dalmau
Journal:  N Engl J Med       Date:  1999-06-10       Impact factor: 91.245

5.  Paraneoplastic limbic encephalitis presenting as acute viral encephalitis.

Authors:  E Kararizou; I Markou; I Zalonis; K Gkiatas; N Triantafyllou; G Kararizos; D Likomanos; T Zambelis; D Vassilopoulos
Journal:  J Neurooncol       Date:  2005-11       Impact factor: 4.130

6.  Clinical outcome of patients with anti-Hu-associated encephalomyelitis after treatment of the tumor.

Authors:  F Keime-Guibert; F Graus; P Broët; R Reñé; J L Molinuevo; C Ascaso; J Y Delattre
Journal:  Neurology       Date:  1999-11-10       Impact factor: 9.910

7.  BR serine/threonine kinase 2: a new autoantigen in paraneoplastic limbic encephalitis.

Authors:  Lidia Sabater; Manuel Gómez-Choco; Albert Saiz; Francesc Graus
Journal:  J Neuroimmunol       Date:  2005-09-13       Impact factor: 3.478

8.  Pathology of pure hippocampal sclerosis in a patient with dementia and Hodgkin's disease: the Ophelia syndrome.

Authors:  Toshiya Shinohara; Hideaki Kojima; Nishio Nakamura; Akihiko Ogata; Tomoko Betsuyaku; Akihiko Suzuki; Youichi Maki; Kazuo Nagashima
Journal:  Neuropathology       Date:  2005-12       Impact factor: 1.906

9.  Recommended diagnostic criteria for paraneoplastic neurological syndromes.

Authors:  F Graus; J Y Delattre; J C Antoine; J Dalmau; B Giometto; W Grisold; J Honnorat; P Sillevis Smitt; Ch Vedeler; J J G M Verschuuren; A Vincent; R Voltz
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-08       Impact factor: 10.154

10.  Antibody-positive paraneoplastic neurologic syndromes: value of CT and PET for tumor diagnosis.

Authors:  Rainer Linke; Mira Schroeder; Thomas Helmberger; Raymond Voltz
Journal:  Neurology       Date:  2004-07-27       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.